Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sickle-Cell Disease Nos With Crisis”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06989567
What this trial is testing

Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis

Who this might be right for
Sickle Cell Disease
Asklepion Pharmaceuticals, LLC 120
Not applicableStudy completedNCT03977532
What this trial is testing

Study of a Red Blood Cell Deformability Parameter in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Assistance Publique Hopitaux De Marseille 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT06315920
What this trial is testing

Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department

Who this might be right for
Sickle-Cell Disease with Crisis
Oman Medical Speciality Board 226
Not applicableLooking for participantsNCT06619197
What this trial is testing

Exploratory Study on Global Reflexology in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease (SCD)
Hospices Civils de Lyon 30
Testing effectiveness (Phase 2)WithdrawnNCT00711698
What this trial is testing

Comparison of Patient Controlled Analgesia (PCA) Versus Bolus Narcotic Therapy for the Treatment of Vaso-Occlusive Crisis (VOC)

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Crisis
Johns Hopkins University
Not applicableLooking for participantsNCT03976180
What this trial is testing

High-flow Oxygen for Vaso-occlusive Pain Crisis

Who this might be right for
Sickle Cell Disease
Assistance Publique - Hôpitaux de Paris 350
Not applicableUnknownNCT02573714
What this trial is testing

Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises

Who this might be right for
Sickle Cell Disease
Cameroon Baptist Convention Health 160
Early research (Phase 1)Study completedNCT00005783
What this trial is testing

A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders

Who this might be right for
Hemoglobin SC DiseaseSickle Cell Anemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Testing effectiveness (Phase 2)Looking for participantsNCT06635902
What this trial is testing

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Pain Episode
Suvankar Majumdar 99
Not applicableUnknownNCT03971136
What this trial is testing

Pulmonary Ultrasound in the Diagnosis of Acute Thoracic Syndrome in Vaso-occlusive Sickle Cell Crisis

Who this might be right for
Sickle-Cell Disease Nos With Crisis
Centre Hospitalier Intercommunal Creteil 150
Testing effectiveness (Phase 2)Ended earlyNCT04852172
What this trial is testing

L-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive Crisis (VOC)

Who this might be right for
Acute Vaso Occlusive Crisis (VOC)
Asklepion Pharmaceuticals, LLC 30
Testing effectiveness (Phase 2)Looking for participantsNCT06699849
What this trial is testing

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Who this might be right for
Sickle Cell Disease Vaso-occlusive Crisis
CSL Behring 70
Testing effectiveness (Phase 2)Study completedNCT01518218
What this trial is testing

Effectiveness of Laying-on-of-hands for Sickle Cell Disease

Who this might be right for
Sickle Cell DiseasePain Crisis RecurrentAnemia+2 more
MOA Health Science Foundation 40
Testing effectiveness (Phase 2)Ended earlyNCT01522196
What this trial is testing

Varespladib Infusion in Subjects With Sickle Cell Disease.

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Crisis
Anthera Pharmaceuticals 2
Not applicableActive Not RecruitingNCT05675436
What this trial is testing

Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease

Who this might be right for
Sickle Cell AnemiaSickle Cell ThalassemiaSickle Cell Pain+5 more
National Heart, Lung, and Blood Institute (NHLBI) 6
Early research (Phase 1)Study completedNCT02989701
What this trial is testing

Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease Without Crisis
Alessandra Biffi 6
Post-approval studies (Phase 4)Study completedNCT04662931
What this trial is testing

An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients

Who this might be right for
Sickle Cell Disease (SCD)
Novartis Pharmaceuticals 140
Large-scale testing (Phase 3)Study completedNCT02187003
What this trial is testing

Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease

Who this might be right for
Anemia, Sickle Cell
Biossil Inc. 345
Large-scale testing (Phase 3)Ended earlyNCT00102791
What this trial is testing

A Stratified Sickle Event Randomized Trial (ASSERT)

Who this might be right for
Sickle Cell Disease
Icagen 297
Testing effectiveness (Phase 2)Study completedNCT03264989
What this trial is testing

Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)

Who this might be right for
Sickle Cell Disease (SCD)
Novartis Pharmaceuticals 57
Load More Results